Literature DB >> 22835453

How does TGF-β mediate tubulointerstitial fibrosis?

Leslie Gewin1, Roy Zent.   

Abstract

Tubulointerstitial fibrosis mediates the development of end-stage renal disease from renal injuries of all etiologies and is considered an important predictor of renal survival. Transforming growth factor-β (TGF-β) is one of the most important growth factors that promotes tubulointerstitial fibrosis, but the mechanisms whereby this occurs are not well defined. This is because TGF-β has pleiotropic effects that depend on the target cell type. This review discusses how TGF-β signaling in each of the relevant cell types (eg, tubular epithelium, fibroblasts) may contribute to tubulointerstitial fibrosis progression and suggests ways in which future research can improve our understanding of TGF-β-mediated tubulointerstitial fibrosis. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22835453      PMCID: PMC4948283          DOI: 10.1016/j.semnephrol.2012.04.001

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  77 in total

Review 1.  TGF-beta activation by traction?

Authors:  Jorma Keski-Oja; Katri Koli; Harald von Melchner
Journal:  Trends Cell Biol       Date:  2004-12       Impact factor: 20.808

2.  Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas.

Authors:  E P Böttinger; J L Jakubczak; I S Roberts; M Mumy; P Hemmati; K Bagnall; G Merlino; L M Wakefield
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

3.  PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction.

Authors:  T Oda; Y O Jung; H S Kim; X Cai; J M López-Guisa; Y Ikeda; A A Eddy
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

4.  Transforming growth factor beta and cell cycle regulation.

Authors:  M G Alexandrow; H L Moses
Journal:  Cancer Res       Date:  1995-04-01       Impact factor: 12.701

Review 5.  Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?

Authors:  Wilhelm Kriz; Brigitte Kaissling; Michel Le Hir
Journal:  J Clin Invest       Date:  2011-02       Impact factor: 14.808

6.  Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury.

Authors:  R Gisli Jenkins; Xiao Su; George Su; Christopher J Scotton; Eric Camerer; Geoffrey J Laurent; George E Davis; Rachel C Chambers; Michael A Matthay; Dean Sheppard
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

7.  Transforming growth factor-beta receptor types I and II are expressed in renal tubules and are increased after chronic unilateral ureteral obstruction.

Authors:  P M Sutaria; M Ohebshalom; T A McCaffrey; E D Vaughan; D Felsen
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

8.  Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells .

Authors:  M Kitamura; T Sütö; T Yokoo; F Shimizu; L G Fine
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

9.  Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells.

Authors:  E Van Obberghen-Schilling; N S Roche; K C Flanders; M B Sporn; A B Roberts
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

10.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.

Authors:  D R Edwards; G Murphy; J J Reynolds; S E Whitham; A J Docherty; P Angel; J K Heath
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  41 in total

Review 1.  The emerging role of the inflammasome in kidney diseases.

Authors:  Anthony Chang; Kichul Ko; Marcus R Clark
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-05       Impact factor: 2.894

2.  Skin Gene Expression Is Prognostic for the Trajectory of Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis.

Authors:  Giuseppina Stifano; Thierry Sornasse; Lisa M Rice; Leo Na; Haiyin Chen-Harris; Dinesh Khanna; Angelika Jahreis; Yuqing Zhang; Jeff Siegel; Robert Lafyatis
Journal:  Arthritis Rheumatol       Date:  2018-06       Impact factor: 10.995

3.  Renal release of N-acetyl-seryl-aspartyl-lysyl-proline is part of an antifibrotic peptidergic system in the kidney.

Authors:  Cesar A Romero; Nitin Kumar; Pablo Nakagawa; Morel E Worou; Tang-Dong Liao; Edward L Peterson; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-07

Review 4.  Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD.

Authors:  David A Ferenbach; Joseph V Bonventre
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

5.  Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.

Authors:  Xiwu Chen; Hongtao Wang; Hong-Jun Liao; Wen Hu; Leslie Gewin; Glenda Mernaugh; Sheng Zhang; Zhong-Yin Zhang; Lorenzo Vega-Montoto; Roberto M Vanacore; Reinhard Fässler; Roy Zent; Ambra Pozzi
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

6.  The kielin/chordin-like protein (KCP) attenuates high-fat diet-induced obesity and metabolic syndrome in mice.

Authors:  Abdul Soofi; Katherine I Wolf; Margo P Emont; Nathan Qi; Gabriel Martinez-Santibanez; Edward Grimley; Wesam Ostwani; Gregory R Dressler
Journal:  J Biol Chem       Date:  2017-04-19       Impact factor: 5.157

7.  Proximal tubule PPARα attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction.

Authors:  Shenyang Li; Nithya Mariappan; Judit Megyesi; Brian Shank; Krishnaswamy Kannan; Sue Theus; Peter M Price; Jeremy S Duffield; Didier Portilla
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-26

8.  Macrophages regulate renal fibrosis through modulating TGFβ superfamily signaling.

Authors:  Bing Shen; Xiuheng Liu; Yu Fan; Jianxin Qiu
Journal:  Inflammation       Date:  2014-12       Impact factor: 4.092

9.  Kielin/chordin-like protein attenuates both acute and chronic renal injury.

Authors:  Abdul Soofi; Peng Zhang; Gregory R Dressler
Journal:  J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 10.121

Review 10.  Acute kidney injury and chronic kidney disease: From the laboratory to the clinic.

Authors:  David A Ferenbach; Joseph V Bonventre
Journal:  Nephrol Ther       Date:  2016-03-10       Impact factor: 0.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.